Regeneron buys bankrupt 23andMe for $256m
23andMe has found itself a buyer after biotech Regeneron won an auction to buy the bankrupt genetics company for $256m. As …
Post
-
-
Innovative Health awarded $147m in antitrust lawsuit against J&J’s Biosense Webster
Innovative Health has been awarded $147m in damages from a lawsuit against Biosense Webster relating to the Johnson & Johnson …
-
University of Bath develops wearable device for continuous heart monitoring
Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the …
-
Intravascular lithotripsy: market competition and clinical potential
A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather …
-
Neuromodulation: rewiring healthcare?
Once niche, the field of neuromodulation is now accelerating toward real-world breakthroughs for conditions such as tinnitus, substance use disorder, …
-
KTU scientists develop system for post-stroke monitoring
Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke monitoring, which also concurrently measures …
-
Huma sets stage for M&A strategy with Eckuity Capital partnership
British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an "aggressive" new M&A strategy. Huma …
-
FDA grants 510(k) clearance to Fujirebio’s blood-based test for Alzheimer’s
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio …
-
GE HealthCare secures FDA clearance and CE mark for deep learning tech
GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology, as …
-
STAAR Surgical plans $30m share buyback despite China market woes
Shares in STAAR Surgical jumped today (16 May) after the implantable lens developer revealed plans to bring $30m worth of …
-
Intalight gains CE mark approval for DREAM OCT platform
Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT [optical coherence tomography] platform, allowing the company …
-
OncoHost wins €2.5m grant to advance precision oncology
OncoHost has secured a €2.5m ($2.8m) grant from the EIC Transition Programme, an initiative under the EU’s broader Horizon Europe …
-
Abbott’s studies show CGM technology linked to lower heart hospitalisation risk
Abbott's REFLECT real-world retrospective studies indicate that FreeStyle Libre continuous glucose monitoring (CGM) technology use is linked to a significant …
-
Are regulators keeping pace with AI adoption in clinical trials?
AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, identifying suitable patients …
-
FDA grants breakthrough device status for Elucent’s EnVisio X1 system
The US Food and Drug Administration (FDA) has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence …
